Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect

BACKGROUND: Monoclonal antibodies (mAbs) have been used for cancer therapy. They are large and have some disadvantages limiting their use. Smaller antibody fragments are needed as their alternatives. A fully human single-domain antibody (sdAb) has a small size of only 15 kDa and consists of only the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tao, Liu, Xue, Hong, Haifeng, Wei, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541222/
https://www.ncbi.nlm.nih.gov/pubmed/33023595
http://dx.doi.org/10.1186/s12967-020-02538-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541222/
https://www.ncbi.nlm.nih.gov/pubmed/33023595
http://dx.doi.org/10.1186/s12967-020-02538-y

Ejemplares similares